請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16691
標題: | 利用基因轉殖鼠 J20 模式探討 Monascus purpureus NTU 568
發酵產物對阿茲海默症病徵延緩及改善記憶學習能力之研究 The study of fermented product of Monascus purpureus NTU 568 to ameliorate learning/memory impairment and Alzheimer’s disease pathophysiology in J20 Alzheimer’s disease transgenic mice |
作者: | Cheng-Han Yang 楊承翰 |
指導教授: | 潘子明(Tzu-Ming Pan) |
關鍵字: | 阿茲海默症,基因轉殖鼠J20,紅麴山藥,rosiglitazone,monascin,ankaflavin,PPARγ 促效劑。, Alzheimer’s disease,transgenic mice J20,red mold dioscorea,rosiglitazone,monascin,ankaflavin,PPARγ agonist., |
出版年 : | 2014 |
學位: | 碩士 |
摘要: | In the recent research, it has been discovered that red mold rice has the potential to ameliorate the symptom of Alzheimer’s disease (AD), by the functional factor such as monacolin K, γ-aminobutyric acid (GABA), dimerumic acid, ankaflavin and monascin. Using dioscorea as substrate for Monascus purpureus fermentation, it can produce higher amount of functional ingredients, ankaflvin and monascin. In this study, we investigate the effect of red mold dioscorea (RMD) to ameliorate Alzheimer’s disease pathophysiology. Using 4 month-old Alzheimer’s disease transgenic mice J20 feeding with RMD for two months, we found that J20 mice fed with RMD have better learning and memory ability then the control group in behavior test such as passive avoidance and Morris water maze. Analyzing the symptoms related to AD, we found that in the brain of J20 mice fed with RMD, there’s a significant decrease in the amount of Aβ1-40, 1-42 and enzyme activity of acetylcholinesterase. After confirming the effect of RMD in AD, we use positive control, rosiglitazone group as reference to investigate the mechanism of RMD to ameliorate AD. In decreasing p-tau level, activating the CD36 marker gene expression which related to microglia clearing Aβ, decreasing gene expression of γ-secretase, we found that RMD has the same effect as rosiglitazone, a PPARγ agonist. According to the previous research that pigments in RMD, monascin and ankaflavin, have the characteristic of PPARγ agonist combined with our results, we assumed that one of the mechanism of RMD to ameliorate AD may through monascin and ankaflavin, as PPAR γagonist rosiglitazone, activate PPARγ to effect it. |
URI: | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16691 |
全文授權: | 未授權 |
顯示於系所單位: | 生化科技學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 4.53 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。